Nachrichten zur Pfizer Inc. Aktie

Pfizer Prices $31 Billion Debt Offering to Fund Seagen Acquisition

Pfizer's acquisition of cancer-focused biotech Seagen, announced in March, would be its biggest since 2009. The deal faces risks....…

Pfizer Sells $31 Billion of Bonds in Fourth-Largest Deal Ever

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-Pfizer plans $31 bln debt offering to fund Seagen takeover

... 16 (Reuters) - Pfizer Inc said on Tuesday it plans to raise $31 billion......…

Pfizer borrows $31 billion in mega bond deal as debt issuance picks up ahead of debt-ceiling deadline

Pharmaceutical giant Pfizer secures $31 billion in financing on Tuesday, as companies pick up the borrowing pace ahead of a…

Pfizer plans to raise $31 billion from debt offering to finance Seagen takeover

...(Reuters) - Pfizer Inc said on Tuesday it plans to raise $31......…

Pfizer plans to raise $31 bln from debt offering to finance Seagen takeover

...May 16 (Reuters) - Pfizer Inc said on Tuesday it plans to raise $31......…

Daybreak: Pfizer Sells Bonds to Fund Seagen Deal

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer bond offering to fund Seagen deal said to among largest on record

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer Kicks Off Jumbo Bond Deal to Buy Seagen as FTC Steps Up ...

Um den gesamten Artikel unter news.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

The Zacks Analyst Blog Highlights Visa, Pfizer, SAP SE, International Business Machines and The Boeing

Visa, Pfizer, SAP SE, International Business Machines and The Boeing are part of the Zacks top Analyst Blog....…

IDEAYA Announces Amended Clinical Trial Collaboration And Supply Agreements With Pfizer

NEW YORK CITY (dpa-AFX) - IDEAYA Biosciences, Inc. (IDYA) has amended its clinical trial collaboration and supply agreements with Pfizer…

Ideaya, Pfizer amend clinical trials supply contacts for darovasertib, Xalkori for eye cancer

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Reports for Visa, Pfizer & SAP

Todays Research Daily features new research reports on 16 major stocks, including Visa Inc. (V), Pfizer Inc. (PFE) and SAP…

Pfizer launches debt offering for Seagen acquisition

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer, Seagen filed with FTC, DOJ on Friday in regards to $43B deal

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: Downgrade

Tokio (www.aktiencheck.de) - Rating-Update: Die Analysten von Daiwa Capital Markets stuft die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol:…

Judge Orders FDA To Speed Up Release Of COVID-19 Vaccine Trial Data From 23.5 Years To Just 2

Judge Orders FDA To Speed Up Release Of COVID-19 Vaccine Trial Data From 23.5 Years To Just 2 …

Covid-19 vaccines cause myocarditis in youngsters, says study

By Luís Batistela The vaccines from Pfizer and Moderna are causing myocarditis in young people between 13 and 21 years…

Healthcare Stocks Are on Sale. These 2 Have Strong Growth Prospects.

Healthcare has had the greatest earnings growth of any sector since the mid-1980s. Why Pfizer and Stryker are two favorite…

Friday’s Top Analyst Upgrades and Downgrades: Alcoa, Alphabet, Block, Disney, Kraft Heinz, Mosaic, Pfizer, Roblox, Walmart and More

Fridays top analyst upgrades and downgrades included Albemarle, Alcoa, Alphabet, Block, CF Industries, Kraft Heinz, Livent, Mosaic, Norfolk Southern, Pfizer,…

Heres why Covid vaccines will still be free for uninsured Americans as public health emergency ends

The Biden administration and drugmakers Pfizer and Moderna have announced programs that aim to help uninsured Americans access Covid shots…

Pfizer CEO says Medicare will likely face legal action over drug price negotiations

Pfizer CEO Albert Bourla argued the Biden administrations plan will cut profits and force Big Pharma companies to pull back…

Pfizer pouring COVID profits into cancer battle, CEO Bourla says

...By Michael Erman (Reuters) - Pfizer Inc is pouring the windfall... Inc, Chief Executive Albert Bourla said…

Niklas Prager appointed new CEO of SmartCella

SmartCella Holding AB today announces that Niklas Prager has been appointed as the new CEO. SmartCella is an innovative biotech…

Lightning Round: Too early to bet on Uranium Energy stock

'Mad Money' host Jim Cramer weighs in on stocks including: Pfizer, Tradeweb Markets, Block, Google, Uranium Energy, Kimbell Royalty Partners,…

Form 10-Q PFIZER INC For: Apr 02

Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…

Vaccine maker chops a quarter of global workforce as COVID eases

Novavax seeks to slash expenses while dealing with an uncertain future after losing the vaccination race against rivals Pfizer and…

XETR : DIVIDEND/INTEREST INFORMATION - 11.05.2023 - US7170811035

Das Instrument PFE US7170811035 PFIZER INC. DL-,05 EQUITY wird cum Dividende/Zinsen gehandelt am…

Insiderhandel: Aufsichtsrat kauft Aktien von Pfizer im Wert von 38.425$

Gottlieb, Scott - Aufsichtsrat - Tag der Transaktion: 2023-05-05...…

Insiderhandel: Aufsichtsrat kauft Aktien von Pfizer im Wert von 38.580$

Gottlieb, Scott - Aufsichtsrat - Tag der Transaktion: 2023-05-08...…

Thermo Fisher, Pfizer partner for genomic cancer testing

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Pfizer: Kursziel reduziert

London (www.aktiencheck.de) - Rating-Update: Carter Gould, Analyst von Barclays, bewertet die Aktie von Pfizer Inc. (ISIN: US7170811035, WKN: 852009, Ticker-Symbol:…

Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know

Zacks.com users have recently been watching Pfizer (PFE) quite a bit. Thus, it is worth knowing the facts that could…

Keine Milliardengewinne mehr - Das Ende des Corona-Booms erreicht die Impfstoffhersteller

Nach Pfizer vermeldet auch die deutsche Biontech ein Ende der extremen Übergewinne. Beide kalkulieren mit einem Wiederaufflammen der Nachfrage. Aber…

BioNTech bekommt Ende des Corona-Booms zu spüren

Frankfurt (Reuters) - Beim Biotechunternehmen BioNTech verliert das Milliardengeschäft mit Corona-Impfstoffen an Schwung.

Der Umsatz sank im ersten Quartal auf…

Arvinas and Pfizer Announce Upcoming Vepdegestrant (ARV-471) Poster Presentations at the 2023 European Society for Medical Oncology (ESMO) Breast Cancer Annual Congress

NEW HAVEN, Conn. and NEW YORK, May 08, 2023 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) and Pfizer…

dpa-AFX ProFeed